Real-World Evidence With Five-Year Data (2017-2022) on the use of Cladribine Tablets in Patients With Multiple Sclerosis in England: An Updated Analysis From the CLARENCE Study

被引：0
作者：
Brownlee, Wallace [1 ]
Amin, Amerah [2 ]
Ashton, Luke [2 ]
Herbert, Alex [2 ]
机构：
[1] UCL Inst Neurol, Queen Sq MS Ctr, London, England
[2] Merck Serono Ltd, Merck KGaA, Feltham, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1558/603
引用
收藏
页码：993 / 994
页数：2
相关论文
共 50 条
[31]   Combining Nimotuzumab With Chemotherapy for Patients With Locally Advanced and Intermediate-Stage Nasopharyngeal Cancer: A Retrospective Comparison Study Using Five-Year, Real-World Survival Data [J].
Rachman, Andhika ;
Sari, Sakinah Rahma ;
Munandar, Arie ;
Adham, Marlinda ;
Hutajulu, Susanna H. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
[32]   A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' [J].
Patti, Francesco ;
Chisari, Clara Grazia ;
Fernandez, Oscar ;
Sarroca, Jorge ;
Ferrer-Picon, Elena ;
Hernandez Vicente, Francisco ;
Vila Silvan, Carlos .
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (09) :2744-2753
[33]   Characterizing up to 2 years of ofatumumab onboarding and utilization among real-world relapsing multiple sclerosis patients in Australia the EAFToS Secondary Use of Data Study [J].
van der Walt, Anneke ;
Broadley, Simon ;
Burton, Jason ;
Hardy, Todd ;
Kemp, Clare ;
Walker, Rob ;
Berry, Patricia ;
Martel, Kate ;
Lam, Lien ;
Nelson, Morag .
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 :641-642
[34]   Characterizing up to 2 years of Ofatumumab onboarding and utilization among real-world relapsing multiple sclerosis patients in Australia - the EAFToS Secondary Use of Data Study [J].
Nelson, Morag ;
Van der Walt, Anneke ;
Broadley, Simon ;
Burton, Jason ;
Hardy, Todd ;
Kemp, Clare ;
Walker, Rob ;
Berry, Patricia ;
Lam, Lien .
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) :NP17-NP17
[35]   Real-world data from the TACO (Teriflunomide in relapsing remitting multiple sclerosis patients assessing clinical benefit and patient-reported outcomes) study [J].
Gobbi, C. ;
Achtnichts, L. ;
Derfuss, T. ;
Stellmes, P. ;
Kamm, C. P. ;
Agosti, R. ;
Czaplinksi, A. ;
Salmen, A. ;
Zecca, C. ;
Roesch, N. ;
Kaiser, C. .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 :755-755
[36]   Long-Term Efficacy and Safety of Everolimus-Eluting Stent Implantation in Japanese Patients with Acute Coronary Syndrome: Five-Year Real-World Data from the Tokyo-MD PCI Study [J].
Yoshikawa, Shunji ;
Ashikaga, Takashi ;
Miyazaki, Toru ;
Kurihara, Ken ;
Hirao, Kenzo .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2019, 2019
[37]   OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany [J].
Ziemssen, Tjalf ;
Richter, Stephan ;
Maeurer, Mathias ;
Buttmann, Mathias ;
Kreusel, Boris ;
Poehler, Anne-Maria ;
Lampl, Maren ;
Linker, Ralf A. .
FRONTIERS IN NEUROLOGY, 2022, 13
[38]   Assessing no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis receiving fingolimod: results from a longitudinal, multicenter, real-world study [J].
Weinstock-Guttman, Bianca ;
Medin, Jennie ;
Khan, Nasreen ;
Korn, Jonathan ;
Price, Jenny ;
Silva, Diego ;
Lathi, Ellen ;
Silversteen, Jason ;
Edwards, Keith ;
Zivadinov, Robert .
NEUROLOGY, 2017, 88
[39]   Real-World Data from a Post-Approval Safety Surveillance Study of Tofacitinib Vs Biologic Dmards and Conventional Synthetic Dmards: Five-Year Results from a US-Based Rheumatoid Arthritis Registry [J].
Kremer, Joel ;
Cappelli, Laura C. ;
Etzel, Carol J. ;
Greenberg, Jeffrey ;
Geier, Jamie ;
Madsen, Ann ;
Chen, Connie ;
Onofrei, Alina ;
Barr, Christine J. ;
Pappas, Dimitrios A. ;
Dandreo, Kimberly J. ;
Shapiro, Andrea ;
Connell, Carol A. ;
Kavanaugh, Arthur .
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[40]   Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study [J].
Baudrexl, Josefine ;
Sakkas, Andreas ;
Pietzka, Sebastian ;
Derka, Spyridoula ;
Vairaktari, Georgia ;
Scheurer, Mario ;
Schramm, Alexander ;
Wilde, Frank ;
Ebeling, Marcel .
ANTICANCER RESEARCH, 2024, 44 (03) :1247-1270
12345